These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31673833)

  • 1. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomicidal, antifibrotic and antioxidant effects of Cucurbita pepo L. seed oil and praziquantel combined treatment for Schistosoma mansoni infection in a mouse model.
    Beshay EVN; Rady AA; Afifi AF; Mohamed AH
    J Helminthol; 2019 May; 93(3):286-294. PubMed ID: 29655377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
    Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
    APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
    Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
    Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.
    Abdel-Hafeez EH; Ahmad AK; Abdulla AM; Aabdel-Wahab S; Mosalem FA
    Parasitol Res; 2012 Aug; 111(2):577-86. PubMed ID: 22398831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
    Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
    Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
    de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
    Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
    Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
    Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
    Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
    Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
    Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
    Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
    Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
    Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.
    Khayeka-Wandabwa C; Kutima H; Nyambati VC; Ingonga J; Oyoo-Okoth E; Karani L; Jumba B; Githuku K; Anjili CO
    Parasit Vectors; 2013 Aug; 6():244. PubMed ID: 23968249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis.
    Soliman MF
    Acta Trop; 2012 Jun; 122(3):261-6. PubMed ID: 22342904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and bioavailability of different praziquantel brands.
    Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
    Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.